- Corporate Officers - S
- Soteropoulos Paula
Insider Trading History of Soteropoulos Paula
The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Soteropoulos Paula since 2018.
This trader's CIK number is 1692444.
At the time of last reporting, Soteropoulos Paula was the Officer of Dianthus Therapeutics, Inc. /de/. (stock ticker symbol DNTH).
Also see all insider trading activities at Dianthus Therapeutics, Inc. /de/.
Note that in the past
Soteropoulos Paula also reported insider trading activities as an insider of the following companies:
Yearly summary of insider trading at Dianthus Therapeutics, Inc. /de/ (DNTH) by Soteropoulos Paula
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2026 | DNTH | 0 | $0 | 27,594 | $2,153,711 | 27,594 | $232,893 |
Yearly summary of insider trading at Uniqure N.v. (QURE) by Soteropoulos Paula
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2024 | QURE | 0 | $0 | 2,220 | $11,410 | 0 | $0 |
| 2023 | QURE | 0 | $0 | 8,659 | $186,410 | 6,000 | $32,220 |
| 2022 | QURE | 0 | $0 | 6,796 | $167,410 | 6,200 | $0 |
| 2021 | QURE | 0 | $0 | 504 | $18,950 | 0 | $0 |
| 2020 | QURE | 0 | $0 | 5,929 | $396,285 | 0 | $0 |
| 2019 | QURE | 0 | $0 | 14,792 | $929,258 | 2,000 | $10,740 |
| 2018 | QURE | 0 | $0 | 2,878 | $53,329 | 0 | $0 |
Yearly summary of insider trading at Akcea Therapeutics, Inc. (AKCA) by Soteropoulos Paula
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2019 | AKCA | 0 | $0 | 50,173 | $1,611,632 | 2,112,034 | $17,624,133 |
Insider trading activities at 3 companies by Soteropoulos Paula:
1. Dianthus Therapeutics, Inc. /de/ (DNTH)
2. Uniqure N.v. (QURE)
3. Akcea Therapeutics, Inc. (AKCA)
Table 1. Insider trading of Dianthus Therapeutics, Inc. /de/ (DNTH) by Soteropoulos Paula
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2026-03-24 | DNTH | Option Ex | 27,594 | 8.44 | 232,893 |
| 2026-03-24 | DNTH | Sale | 27,594 | 78.05 | 2,153,711 |
Table 2. Insider trading of Uniqure N.v. (QURE) by Soteropoulos Paula
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2024-06-13 | QURE | Sale | 2,220 | 5.14 | 11,410 |
| 2023-06-16 | QURE | Sale | 2,275 | 18.99 | 43,202 |
| 2023-02-27 | QURE | Sale | 384 | 19.97 | 7,668 |
| 2023-01-18 | QURE | Sale | 6,000 | 22.59 | 135,540 |
| 2023-01-18 | QURE | Option Ex | 6,000 | 5.37 | 32,220 |
| 2022-11-29 | QURE | Option Ex | 6,200 | .00 | 0 |
| 2022-11-29 | QURE | Sale | 6,200 | 25.38 | 157,356 |
| 2022-02-28 | QURE | Sale | 596 | 16.87 | 10,054 |
| 2021-03-02 | QURE | Sale | 504 | 37.60 | 18,950 |
| 2020-02-05 | QURE | Sale | 2,122 | 61.05 | 129,558 |
| 2020-01-28 | QURE | Sale | 807 | 62.19 | 50,187 |
| 2020-01-07 | QURE | Sale | 3,000 | 72.18 | 216,540 |
| 2019-12-13 | QURE | Option Ex | 2,000 | 5.37 | 10,740 |
| 2019-12-13 | QURE | Sale | 2,000 | 70.50 | 141,000 |
| 2019-12-09 | QURE | Sale | 2,500 | 67.50 | 168,750 |
| 2019-12-06 | QURE | Sale | 9,082 | 64.04 | 581,611 |
| 2019-01-28 | QURE | Sale | 1,210 | 31.32 | 37,897 |
| 2018-01-29 | QURE | Sale | 2,878 | 18.53 | 53,329 |
Table 3. Insider trading of Akcea Therapeutics, Inc. (AKCA) by Soteropoulos Paula
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2019-09-26 | AKCA | Option Ex | 2,061,861 | 8.39 | 17,299,013 |
| 2019-04-08 | AKCA | Option Ex | 1,787 | 6.48 | 11,579 |
| 2019-04-05 | AKCA | Sale | 30,000 | 32.11 | 963,300 |
| 2019-04-05 | AKCA | Option Ex | 30,000 | 6.48 | 194,400 |
| 2019-04-08 | AKCA | Sale | 1,787 | 32.17 | 57,480 |
| 2019-03-06 | AKCA | Option Ex | 18,386 | 6.48 | 119,141 |
| 2019-03-06 | AKCA | Sale | 18,386 | 32.14 | 590,852 |
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above table cannot be completely guaranteed as to their accuracy.
For more information regarding the trades made by Soteropoulos Paula
(Officer of Dianthus Therapeutics, Inc. /de/ at the time of this reporting) see
the Securities and Exchange Commission (SEC) website.